Can High-Tech toothbrushes protect gums in scleroderma?
NCT ID NCT04627857
First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time
Summary
This trial tests whether using a sonic toothbrush and a water flosser improves gum health better than a standard manual toothbrush in people with systemic sclerosis, a rare disease that often affects the mouth. About 20 adults with the condition will be randomly assigned to one of three oral hygiene routines and monitored for changes in plaque over four weeks. The goal is to see if these devices can make daily oral care easier and more effective for patients with limited hand function.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Oral hygiene devices: manual toothbrush, sonic toothbrush, and water flosser (Philips Sonicare AirFloss)
- What this could lead to
- If effective, these devices could offer a practical way to improve gum health and quality of life for people with systemic sclerosis.
- What could go wrong
- This is a small, early-stage trial with only 20 participants, so results may not apply broadly. The devices may not significantly outperform manual brushing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Jul 2021
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult male or female ≥ 18 years (18th birthday completed) * Affiliation to a social welfare system * Signed informed consent form * More than 12 natural teeth suitable for evaluation * Systemic sclerosis with cutaneous involvement with a diagnosis based on American College of Rheumatology (ACR) and LeRoy and Metzger criteria Exclusion Criteria: * Localized scleroderma or systemic sclerosis without cutaneous involvement ("sine scleroderma" limited form) * Less than 12 natural teeth suitable for evaluation and/or mandibular/maxillary complete denture(s) * Other progressive chronic illness /autoimmune disease other than systemic sclerosis (e.g. diabetes) * Another cause of mucocutaneous sclerosis (e.g. radiotherapy involving the oro-facial region) * Current use of sonic toothbrush and/or dental water flosser * Severe manual handicap preventing the patient from holding a toothbrush with a large handle * Oral antiseptics (e.g. chlorhexidin mouthwashes) * Ongoing medical treatment inducing a significant modification of the gingival state (e.g. anti-epileptic drugs) * Smoking (≥ 10 cigarettes per day) * Impossibility to provide accurate information (e.g. emergency situation, comprehension difficulties) * Individual under guardianship, curatorship or judicial protection
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Scleroderma, systemic are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de parodontologie
Strasbourg, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could gum bacteria fuel scleroderma? a new study digs in
- Are women with autoimmune diseases getting the gynecological care they need?
- New shot aims to tame rare autoimmune disease
- Cancer drug shows promise for rare skin disease
- Scientists probe immune Cells' role in scleroderma blood vessel injury
- New drug hope for scleroderma patients with lung complications